SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 190 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $116,000 | +728.6% | 28,019 | +1081.7% | 0.00% | – |
| Q1 2022 | $14,000 | -69.6% | 2,371 | -60.9% | 0.00% | -100.0% |
| Q4 2021 | $46,000 | -67.1% | 6,070 | -48.2% | 0.00% | -60.0% |
| Q2 2021 | $140,000 | +3400.0% | 11,715 | +3844.4% | 0.01% | – |
| Q1 2021 | $4,000 | -91.5% | 297 | -90.1% | 0.00% | -100.0% |
| Q4 2020 | $47,000 | +4600.0% | 2,989 | +1803.8% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 157 | +101.3% | 0.00% | – |
| Q4 2018 | $1,000 | -91.7% | 78 | -87.5% | 0.00% | -100.0% |
| Q1 2018 | $12,000 | +1100.0% | 622 | +776.1% | 0.01% | +500.0% |
| Q3 2017 | $1,000 | -87.5% | 71 | -92.5% | 0.00% | -87.5% |
| Q2 2017 | $8,000 | – | 942 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |